Download PDF
Anästhesiol Intensivmed Notfallmed Schmerzther 2012; 47(11/12): 688-695
DOI: 10.1055/s-0032-1331365
Fachwissen
Anästhesiologie & Schmerzmedizin
© Georg Thieme Verlag Stuttgart · New York

Patienten mit einem komplexen regionalen Schmerzsyndrom (CRPS) – Perioperatives Management und schmerztherapeutische Therapieformen

Anaesthesia and pain therapy – Perioperative management of patients with complex regional pain syndrome
Christos Dimitrios Pouskoulas
,
Armin Aeschbach
,
Wilhelm Ruppen
Further Information

Publication History

Publication Date:
12 December 2012 (online)

Also available at
    Permissions and Reprints

Zusammenfassung

Das komplexe regionale Schmerzsyndrom (complex regional painsyndrome, CRPS) ist eine äußerst komplexe Schmerzerkrankung und stellt an alle Involvierten hohe Ansprüche. Ein Sonderfall ist ein Patient mit einem floriden CRPS oder einem Zustand nach CRPS, der sich einer Operation unterziehen muss. Der Beitrag erläutert Empfehlungen bezüglich des idealen Zeitpunkts der Operation sowie zum perioperativen Management solcher Patienten.Hohe Evidenz für die Prophylaxe eines CRPS nach einem Trauma besteht nur für langfristig verabreichte, hochdosierte Vitamin C-Gaben.

Abstract

The complex regional pain syndrome (CRPS) is indeed a very complex pain situation. The treatment of CRPS is challenging. Patients with an acute CRPS or a CRPS in the past, who have to undergo surgery, provide a special situation. Recommendations for the management of such patients will be described in the article. High degree of evidence exists for high doses of vitamin C to prevent the development of a CRPS in trauma patients.

Kernaussagen

  • Das optimale perioperative Management von Patienten mit einem CRPS stellt an alle involvierten Fachdisziplinen hohe Anforderungen.

  • Operationen bei Patienten mit einem CRPS oder Zustand nach CRPS sollten, wenn immer möglich, vermieden werden.

  • Ist eine Operation bei einem Patienten unumgänglich, sollte möglichst ein Regionalanästhesieverfahren gewählt werden.

  • 500 mg Vitamin C per os während 50 Tagen ist eine effektive Prophylaxe zur Vermeidung eines CRPS nach chirurgisch versorgter Radiusfraktur.

  • Über mehrere Tage verabreichtes hochdosiertes Ketamin scheint beim klinisch aktiven CRPS therapeutisch wirksam zu sein.

  • Die Anwendung von GLOA-Infiltrationen (GLOA = ganglionäre lokale Opioidanalgesie) sowie die Gabe von Calcitonin zur Therapie des CRPS ist umstritten.

  • Viele Fragen bleiben unbeantwortet.

Schlüsselwörter:

komplexes regionales Schmerzsyndrom - complexregional pain syndrome (CRPS) - Operation - Regionalanästhesie - Vitamin C

Keywords:

complexregional pain syndrome (CRPS) - surgery - regional anaesthesia - Vitamin C

Ergänzendes Material

 

  • Literaturverzeichnis

  • 1 Hsu ES. Practical management of complex regional pain syndrome. Am J Ther 2009; 16: 147-154
    CrossrefPubMedGoogle Scholar
  • 2 Baron R, Wasner G. Complex regional pain syndromes. Current pain and headache reports 2001; 5: 114-123
    CrossrefPubMedGoogle Scholar
  • 3 de Mos M, Sturkenboom MC, Huygen FJ. Current understandings on complex regional pain syndrome. Pain Pract 2009; 9: 86-99
    CrossrefPubMedGoogle Scholar
  • 4 Marinus J, Moseley GL, Birklein F et al. Clinical features and pathophysiology of complex regional pain syndrome. Lancet neurology 2011; 10: 637-648
    CrossrefPubMedGoogle Scholar
  • 5 Harden RN, Bruehl S, Perez RS et al. Validation of proposed diagnostic criteria (the "Budapest Criteria") for Complex Regional Pain Syndrome. Pain 2010; 150: 268-274
    CrossrefPubMedGoogle Scholar
  • 6 Turner-Stokes L, Goebel A. Complex regional pain syndrome in adults: concise guidance. Clin Med 2011; 11: 596-600
    CrossrefPubMedGoogle Scholar
  • 7 Ruegg S. Drug treatment of CRPS. Handchir Mikrochir Plast Chir 2010; 42: 19-29
    Article in Thieme ConnectPubMedGoogle Scholar
  • 8 Pak TJ, Martin GM, Magness JL et al. Reflex sympathetic dystrophy. Review of 140 cases. Minn Med 1970; 53: 507-512
    PubMedGoogle Scholar
  • 9 Harden RN, Bruehl S, Stanos S et al. Prospective examination of pain-related and psychological predictors of CRPS-like phenomena following total knee arthroplasty: a preliminary study. Pain 2003; 106: 393-400
    CrossrefPubMedGoogle Scholar
  • 10 Veldman PH, Goris RJ. Surgery on extremities with reflex sympathetic dystrophy. Unfallchirurg 1995; 98: 45-48
    PubMedGoogle Scholar
  • 11 Troeger H. Prophylaxis of CRPS I and recurrent CRPS I. Handchir Mikrochir Plast Chir 2011; 43: 25-31
    Article in Thieme ConnectPubMedGoogle Scholar
  • 12 Lankford LL. Reflex sympathetic dystrophy. In: Green DP. Operative hand surgery. 3rd edition. New York: Churchill Livingstone; 1988: 633-663
    Google Scholar
  • 13 Katz MM, Hungerford DS. Reflex sympathetic dystrophy affecting the knee. J Bone Joint Surg Br 1987; 69: 797-803
    CrossrefPubMedGoogle Scholar
  • 14 Perkins FM, Kehlet H. Chronic pain as an outcome of surgery. A review of predictive factors. Anesthesiology 2000; 93: 1123-1133
    CrossrefPubMedGoogle Scholar
  • 15 Rocco AG. Sympathetically maintained pain may be rekindled by surgery under general anesthesia. Anesthesiology 1993; 79: 865-865
    CrossrefPubMedGoogle Scholar
  • 16 Viel EJ, Pelissier J, Eledjam JJ. Sympathetically maintained pain after surgery may be prevented by regional anesthesia. Anesthesiology 1994; 81: 265-266
    CrossrefPubMedGoogle Scholar
  • 17 Ackerman 3rd WE, Ahmad M. Recurrent postoperative CRPS I in patients with abnormal preoperative sympathetic function. J Hand Surg Am 2008; 33: 217-222
    CrossrefPubMedGoogle Scholar
  • 18 Cramer G, Young BM, Schwarzentraub P et al. Preemptive analgesia in elective surgery in patients with complex regional pain syndrome: a case report. J Foot Ankle Surg 2000; 39: 387-391
    CrossrefPubMedGoogle Scholar
  • 19 Zollinger PE, Tuinebreijer WE, Kreis RW et al. Effect of vitamin C on frequency of reflex sympathetic dystrophy in wrist fractures: a randomised trial. Lancet 1999; 354: 2025-2028
    CrossrefPubMedGoogle Scholar
  • 20 Cazeneuve JF, Leborgne JM, Kermad K et al. Vitamin C and prevention of reflex sympathetic dystrophy following surgical management of distal radius fractures. Acta Orthop Belg 2002; 68: 481-484
    PubMedGoogle Scholar
  • 21 Kissling RO, Bloesch AC, Sager M et al. Prevention of recurrence of Sudeck's disease with calcitonin. Rev Chir Orthop Reparatrice Appar Mot 1991; 77: 562-567
    PubMedGoogle Scholar
  • 22 Riou C, Daoudi Y, Langlais F et al. Can algodystrophy be prevented by thyrocalcitonin?. Rev Chir Orthop Reparatrice Appar Mot 1991; 77: 208-210
    PubMedGoogle Scholar
  • 23 Hannington-Kiff JG. Intravenous regional sympathetic block with guanethidine. Lancet 1974; 1: 1019-1020
    PubMedGoogle Scholar
  • 24 Gschwind C, Fricker R, Lacher G et al. Does peri-operative guanethidine prevent reflex sympathetic dystrophy?. J Hand Surg Br 1995; 20: 773-775
    PubMedGoogle Scholar
  • 25 Jadad AR, Carroll D, Glynn CJ et al. Intravenous regional sympathetic blockade for pain relief in reflex sympathetic dystrophy: a systematic review and a randomized, double-blind crossover study. J Pain Symptom Manage 1995; 10: 13-20
    CrossrefPubMedGoogle Scholar
  • 26 Kingery WS. A critical review of controlled clinical trials for peripheral neuropathic pain and complex regional pain syndromes. Pain 1997; 73: 123-139
    CrossrefPubMedGoogle Scholar
  • 27 Perez RS, Kwakkel G, Zuurmond WW et al. Treatment of reflex sympathetic dystrophy (CRPS type 1): a research synthesis of 21 randomized clinical trials. J Pain Symptom Manage 2001; 21: 511-526
    CrossrefPubMedGoogle Scholar
  • 28 Chaplan SR, Bach FW, Shafer SL et al. Prolonged alleviation of tactile allodynia by intravenous lidocaine in neuropathic rats. Anesthesiology 1995; 83: 775-785
    CrossrefPubMedGoogle Scholar
  • 29 Bach FW, Jensen TS, Kastrup J et al. The effect of intravenous lidocaine on nociceptive processing in diabetic neuropathy. Pain 1990; 40: 29-34
    CrossrefPubMedGoogle Scholar
  • 30 Kastrup J, Petersen P, Dejgard A et al. Intravenous lidocaine infusion – a new treatment of chronic painful diabetic neuropathy?. Pain 1987; 28: 69-75
    CrossrefPubMedGoogle Scholar
  • 31 Marchettini P, Lacerenza M, Marangoni C et al. Lidocaine test in neuralgia. Pain 1992; 48: 377-382
    CrossrefPubMedGoogle Scholar
  • 32 Rowbotham MC, Reisner-Keller LA, Fields HL. Both intravenous lidocaine and morphine reduce the pain of postherpetic neuralgia. Neurology 1991; 41: 1024-1028
    CrossrefPubMedGoogle Scholar
  • 33 Wallace MS, Dyck JB, Rossi SS et al. Computer-controlled lidocaine infusion for the evaluation of neuropathic pain after peripheral nerve injury. Pain 1996; 66: 69-77
    CrossrefPubMedGoogle Scholar
  • 34 Tanelian DL, Brose WG. Neuropathic pain can be relieved by drugs that are use-dependent sodium channel blockers: lidocaine, carbamazepine, and mexiletine. Anesthesiology 1991; 74: 949-951
    CrossrefPubMedGoogle Scholar
  • 35 Koppert W, Ostermeier N, Sittl R et al. Low-dose lidocaine reduces secondary hyperalgesia by a central mode of action. Pain 2000; 85: 217-224
    CrossrefPubMedGoogle Scholar
  • 36 Koppert W, Zeck S, Sittl R et al. Low-dose lidocaine suppresses experimentally induced hyperalgesia in humans. Anesthesiology 1998; 89: 1345-1353
    CrossrefPubMedGoogle Scholar
  • 37 Linchitz RM, Raheb JC. Subcutaneous infusion of lidocaine provides effective pain relief for CRPS patients. Clin J Pain 1999; 15: 67-72
    CrossrefPubMedGoogle Scholar
  • 38 Wallace MS, Ridgeway BM, Leung AY et al. Concentration-effect relationship of intravenous lidocaine on the allodynia of complex regional pain syndrome types I and II. Anesthesiology 2000; 92: 75-83
    CrossrefPubMedGoogle Scholar
  • 39 Schwartzman RJ, Patel M, Grothusen JR et al. Efficacy of 5-day continuous lidocaine infusion for the treatment of refractory complex regional pain syndrome. Pain Med 2009; 10: 401-412
    CrossrefPubMedGoogle Scholar
  • 40 Tremont-Lukats IW, Hutson PR, Backonja MM. A randomized, double-masked, placebo-controlled pilot trial of extended IV lidocaine infusion for relief of ongoing neuropathic pain. Clin J Pain 2006; 22: 266-271
    CrossrefPubMedGoogle Scholar
  • 41 Correll GE, Maleki J, Gracely EJ et al. Subanesthetic ketamine infusion therapy: a retrospective analysis of a novel therapeutic approach to complex regional pain syndrome. Pain Med 2004; 5: 263-275
    CrossrefPubMedGoogle Scholar
  • 42 Koffler SP, Hampstead BM, Irani F et al. The neurocognitive effects of 5 day anesthetic ketamine for the treatment of refractory complex regional pain syndrome. Arch Clin Neuropsychol 2007; 22: 719-729
    CrossrefPubMedGoogle Scholar
  • 43 Sigtermans MJ, van Hilten JJ, Bauer MC et al. Ketamine produces effective and long-term pain relief in patients with Complex Regional Pain Syndrome Type 1. Pain 2009; 145: 304-311
    CrossrefPubMedGoogle Scholar
  • 44 Schwartzman RJ, Alexander GM, Grothusen JR et al. Outpatient intravenous ketamine for the treatment of complex regional pain syndrome: a double-blind placebo controlled study. Pain 2009; 147: 107-115
    CrossrefPubMedGoogle Scholar
  • 45 Ali Z, Raja SN, Wesselmann U et al. Intradermal injection of norepinephrine evokes pain in patients with sympathetically maintained pain. Pain 2000; 88: 161-168
    CrossrefPubMedGoogle Scholar
  • 46 Cepeda MS, Carr DB, Lau J. Local anesthetic sympathetic blockade for complex regional pain syndrome. Cochrane Database Syst Rev CD 004598 2005;
    PubMedGoogle Scholar
  • 47 Nelson DV, Stacey BR. Interventional therapies in the management of complex regional pain syndrome. Clin J Pain 2006; 22: 438-442
    CrossrefPubMedGoogle Scholar
  • 48 Maier C. Ganglionäre lokale Opioidanalgesie (GLOA). Ein neues Therapieverfahren bei persistierenden neuropathischen Schmerzen. Stuttgart: Thieme; 1994
    Google Scholar
  • 49 Knolle E, Kress HG. Ganglionic local opioid analgesia. Clinical effect and local extent. Schmerz 2006; 20: 265-266
    CrossrefPubMedGoogle Scholar
  • 50 Hervonen A, Linnoila I, Pickel VM et al. Localization of [Met5]- and [Leu5]-enkephalin-like immunoreactivity in nerve terminals in human paravertebral sympathetic ganglia. Neuroscience 1981; 6: 323-330
    CrossrefPubMedGoogle Scholar
  • 51 Schultzberg M, Hokfelt T, Terenius L et al. Enkephalin immunoreactive nerve fibres and cell bodies in sympathetic ganglia of the guinea-pig and rat. Neuroscience 1979; 4: 249-270
    CrossrefPubMedGoogle Scholar
  • 52 Di Giulio AM, Yang HY, Lutold B et al. Characterization of enkephalin-like material extracted from sympathetic ganglia. Neuropharmacology 1978; 17: 989-992
    CrossrefPubMedGoogle Scholar
  • 53 Hannington-Kiff JG. Does failed natural opioid modulation in regional sympathetic ganglia cause reflex sympathetic dystrophy?. Lancet 1991; 338: 1125-1127
    CrossrefPubMedGoogle Scholar
  • 54 Arias LM, Bartkowski R, Grossman KL et al. Sufentanil stellate ganglion injection in the treatment of refractory reflex sympathetic dystrophy. Reg Anesth 1989; 14: 90-92
    PubMedGoogle Scholar
  • 55 Elsner F, Radbruch L, Gaertner J et al. Efficacy of opioid analgesia at the superior cervical ganglion in neuropathic head and facial pain. Schmerz 2006; 20: 274-266
    PubMedGoogle Scholar
  • 56 Spacek A, Bohm D, Kress HG. Ganglionic local opioid analgesia for refractory trigeminal neuralgia. Lancet 1997; 349: 1521-1521
    PubMedGoogle Scholar
  • 57 Glynn C, Casale R. Morphine injected around the stellate ganglion does not modulate the sympathetic nervous system nor does it provide pain relief. Pain 1993; 53: 33-37
    CrossrefPubMedGoogle Scholar
  • 58 Spacek A, Orlicek F, Wober C et al. Ganglionic local opioid analgesia in refractory trigeminal neuralgia: Just a placebo? A randomized, controlled, double-blind, cross-over study. The Pain Clinic 2002; 14: 195-200
    CrossrefPubMedGoogle Scholar
  • 59 Goebel A, Lawson A, Allen S et al. Buprenorphine injection to the stellate ganglion in the treatment of upper body chronic pain syndromes. Eur J Pain 2008; 12: 266-274
    CrossrefPubMedGoogle Scholar
  • 60 Prosdocimi M, Finesso M, Gorio A. Enkephalin modulation of neural transmission in the cat stellate ganglion: pharmacological actions of exogenous opiates. J Auton Nerv Syst 1986; 17: 217-230
    CrossrefPubMedGoogle Scholar
  • 61 Urban BJ, McKain CW. Local anesthetic effect of intrathecal normal saline. Pain 1978; 5: 43-52
    CrossrefPubMedGoogle Scholar
  • 62 Spacek A, Hanl G, Groiss O et al. Acupuncture and ganglionic local opioid analgesia in trigeminal neuralgia. Wien Med Wochenschr 1998; 148: 447-449
    PubMedGoogle Scholar
  • 63 Sprotte G. Chronic pain: a problem in nocisuppression?. Cah Anesthesiol 1985; 33: 125-126
    PubMedGoogle Scholar
  • 64 Feldman PH, Goris RJ. Multiple reflex sympathetic dystrophy. Which patients are at risk for developing a recurrence of reflex sympathetic dystrophy in the same or another limb. Pain 1996; 64: 463-466
    CrossrefPubMedGoogle Scholar